Viscosupplementation is the latest treatment which is being rapidly adapted these days for the treatment of osteoarthritis. It is a method of injecting hyaluronic acid in stiff joints specially knees. Due to the global adoption, the Viscosupplementation market is expected to hit $1756 million during 2015-2021 growing at an impressive CAGR of 6% during the forecast period. The main reason behind a solid growth of Viscosupplementation market on the global level is the rapid rise in the elderly population suffering from osteoarthritis. This elderly population is expected to increase in future due to advancement in the healthcare facilities which would ultimately require Disco supplementation for patients suffering from osteoarthritis during the forecast period.
Further, Intra-articular Viscosupplementation with hyaluronic acid (HA) is gaining a good acceptance as a therapeutic alternative to knee replacement surgery in OA in the past decade. North America is expected to be the largest market for Viscosupplementation during the forecast period in which the US being the major contributor to the global market for Viscosupplementation. On the flip side, APAC is seeing good growth in demand for Viscosupplementation fluids due to rising cases of osteoarthritis in countries such as India and China. However, the growing concern of physicians who updated American Academy of Orthopedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will affect in rising insurance denials for Viscosupplementation. Further the price competition and product differentiation are some of the factors that can restrict the smooth growth of the market during the forecast period.